Your browser doesn't support javascript.
loading
Characteristics of sudden hearing loss after different COVID-19 vaccinations: a systematic review and meta-analysis.
Albakri, Khaled; Abdelwahab, Omar Ahmed; Gabra, Mohamed Diaa; Nafady, Mohamed H; Alabdallat, Yasmeen Jamal; Soliman, Ahmed; Cadri, Shirin; Hanaqtah, Balqees; Albazee, Ebraheem.
Afiliación
  • Albakri K; Faculty of Medicine, The Hashemite University, Zarqa, Jordan.
  • Abdelwahab OA; Medical Research Group of Egypt, Cairo, Egypt.
  • Gabra MD; Medical Research Group of Egypt, Cairo, Egypt.
  • Nafady MH; Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
  • Alabdallat YJ; Medical Research Group of Egypt, Cairo, Egypt.
  • Soliman A; Faculty of Medicine, South Valley University, Qena, Egypt.
  • Cadri S; Medical Research Group of Egypt, Cairo, Egypt.
  • Hanaqtah B; Faculty of Applied Health Science Technology, Misr University for Science and Technology, El Giza, Egypt.
  • Albazee E; Radiation Science Department, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Eur Arch Otorhinolaryngol ; 280(12): 5167-5176, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37594544
INTRODUCTION: COVID-19 vaccines are essential to prevent complications and reduce the burden of SARS-CoV-2. However, these vaccines showed side effects such as fatigue, pain, fever, and rarely hearing loss. In this review, we aim to summarize studies investigating hearing loss following COVID-19 vaccination and try to find the possible association and risk factors for this hazardous complication. METHODS: We performed a comprehensive search of five electronic databases (PubMed, Scopus, Web of Science, google scholar, Cochrane) from inception until 9 October 2022. We finally included 16 studies after the first and second scans. We used SPSS to analyze the extracted data. RESULTS: A total of 630 patients were identified, with a mean age of 57.3. Of the patients, 328 out of 609 vaccinated patients took the Pfizer-BioNTech BNT162b2 vaccine, while 242 (40%) took the Moderna COVID-19 vaccine. The mean time from vaccination to hearing impairment was 6.2, ranging from a few hours to one month after the last dose. The results found a significant difference between vaccine types in terms of incidence and prognosis of the condition, while they showed that the number of doses prior to the onset had no significance. CONCLUSION: SNHL has been reported in a small number of people who have received the COVID-19 vaccine, but it is unclear at this time whether the vaccine is directly causing this condition. However, the COVID-19 vaccine has been demonstrated to be safe and effective in preventing illness, and the benefits of vaccination are significant compared to any potential risks. PROTOCOL REGISTRATION: The protocol of this study was registered on Prospero CRD42022367180.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sordera / Pérdida Auditiva Súbita / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans / Middle aged Idioma: En Revista: Eur Arch Otorhinolaryngol Asunto de la revista: OTORRINOLARINGOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Jordania Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sordera / Pérdida Auditiva Súbita / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans / Middle aged Idioma: En Revista: Eur Arch Otorhinolaryngol Asunto de la revista: OTORRINOLARINGOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Jordania Pais de publicación: Alemania